Steve Kim, CEO of Valer As a physician, the odds that you’ve had a negative experience related to the prior authorization process are (unfortunately) highly
What You Should Know: – Array Behavioral Care, the nation’s leading virtual psychiatry and therapy practice providing quality mental health services across the continuum of care,
What You Should Know: – OneCell Diagnostics, a genomics-based precision oncology company, announced today that it has raised $16M in an oversubscribed Series A funding round
Hardman & Co Research Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven 21-Nov-2024 / 11:15 GMT/BST The issuer
EQS-News: APONTIS PHARMA AG / Key word(s): Tender Offer APONTIS PHARMA AG: Condition of Minimum Acceptance in Zentiva’s Voluntary Public Purchase Offer Waived 21.11.2024 /
EQS-News: Pentixapharm Holding AG / Key word(s): Study First Patient Treated in Phase I/II Trial in Acute Myeloid and Acute Lymphoblastic Leukemia with Lu177-PentixaTher, Expanding
EQS-News: MPH Health Care AG / Key word(s): 9 Month figures/Quarter Results EBIT increases to EUR 55.6 million. Equity (net asset value) increases by EUR
Xlife Sciences AG / Key word(s): Expansion/IPO 21-Nov-2024 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is
Hardman & Co Research Hardman & Co Investor Forum Research on Custodian Property Income REIT (CREI): Good momentum, modest risk 20-Nov-2024 / 13:55 GMT/BST The
Hardman & Co Research Hardman & Co Q&A on Duke Capital (DUKE): Equity raise and third-party capital update 20-Nov-2024 / 10:30 GMT/BST The issuer is